BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21787262)

  • 41. Diffuse large B-cell lymphomas of immunoblastic type are a major reservoir for MYC-IGH translocations.
    Horn H; Staiger AM; Vöhringer M; Hay U; Campo E; Rosenwald A; Ott G; Ott MM
    Am J Surg Pathol; 2015 Jan; 39(1):61-6. PubMed ID: 25229766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genome-wide DNA profiling of HIV-related B-cell lymphomas.
    Rinaldi A; Capello D; Zucca E; Gaidano G; Bertoni F
    Methods Mol Biol; 2013; 973():213-26. PubMed ID: 23412793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance and prognosis of MYC translocation in diffuse large B-cell lymphoma.
    Zhang HW; Chen ZW; Li SH; Bai W; Cheng NL; Wang JF
    Hematol Oncol; 2011 Dec; 29(4):185-9. PubMed ID: 21692100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection.
    Chao C; Silverberg MJ; Xu L; Chen LH; Castor B; Martínez-Maza O; Abrams DI; Zha HD; Haque R; Said J
    Clin Cancer Res; 2015 Mar; 21(6):1429-37. PubMed ID: 25589617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synchronous Microscopic Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma of the Adrenal and Lymphoplasmacytic Lymphoma: De Novo Disease or Transformation?
    Moonim MT; Nasir A; Hubbard J; Ketley N; Fields P
    Int J Surg Pathol; 2017 Jun; 25(4):326-332. PubMed ID: 27913781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas.
    Robledo C; García JL; Caballero D; Conde E; Arranz R; Flores T; Grande C; Rodríguez J; García E; Sáez AI; González M; Gutiérrez NC; Piris MA; Hernández JM;
    Cancer; 2009 Aug; 115(16):3728-37. PubMed ID: 19517471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.
    Chigrinova E; Mian M; Scandurra M; Greiner TC; Chan WC; Vose JM; Inghirami G; Chiappella A; Baldini L; Ponzoni M; Ferreri AJ; Franceschetti S; Gaidano G; Tucci A; Facchetti F; Lazure T; Lambotte O; Montes-Moreno S; Piris MA; Nomdedeu JF; Uccella S; Rancoita PM; Kwee I; Zucca E; Bertoni F
    Hematol Oncol; 2011 Mar; 29(1):38-41. PubMed ID: 20635329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
    Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
    Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome.
    Tzankov A; Gschwendtner A; Augustin F; Fiegl M; Obermann EC; Dirnhofer S; Went P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2125-32. PubMed ID: 16609025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.
    Wong KK; Gascoyne DM; Soilleux EJ; Lyne L; Spearman H; Roncador G; Pedersen LM; Møller MB; Green TM; Banham AH
    Oncotarget; 2016 Aug; 7(33):52940-52956. PubMed ID: 27224915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?
    Ok CY; Ye Q; Li L; Manyam GC; Deng L; Goswami RR; Wang X; Montes-Moreno S; Visco C; Tzankov A; Dybkaer K; Zhang L; Abramson J; Sohani AR; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhang S; Parsons BM; Xu M; Møller MB; Winter JN; Piris MA; Xu-Monette ZY; Medeiros LJ; Young KH
    Oncotarget; 2015 Jun; 6(16):13933-45. PubMed ID: 26101854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of genes putatively involved in the pathogenesis of diffuse large B-cell lymphomas by integrative genomics.
    Oudejans JJ; van Wieringen WN; Smeets SJ; Tijssen M; Vosse SJ; Meijer CJ; Meijer GA; van de Wiel MA; Ylstra B
    Genes Chromosomes Cancer; 2009 Mar; 48(3):250-60. PubMed ID: 19051311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma.
    Chang CC; Zhou X; Taylor JJ; Huang WT; Ren X; Monzon F; Feng Y; Rao PH; Lu XY; Fabio F; Hilsenbeck S; Creighton CJ; Jaffe ES; Lau CC
    J Hematol Oncol; 2009 Nov; 2():47. PubMed ID: 19909553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.
    Aricò A; Ferraresso S; Bresolin S; Marconato L; Comazzi S; Te Kronnie G; Aresu L
    PLoS One; 2014; 9(11):e111817. PubMed ID: 25372838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
    Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
    J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma.
    Wenzel SS; Grau M; Mavis C; Hailfinger S; Wolf A; Madle H; Deeb G; Dörken B; Thome M; Lenz P; Dirnhofer S; Hernandez-Ilizaliturri FJ; Tzankov A; Lenz G
    Leukemia; 2013 Jun; 27(6):1381-90. PubMed ID: 23257783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD30 expression and its correlation with MYC and BCL2 in de novo diffuse large B-cell lymphoma.
    Gong QX; Wang Z; Liu C; Li X; Lu TX; Liang JH; Xu W; Li JY; Zhang ZH
    J Clin Pathol; 2018 Sep; 71(9):795-801. PubMed ID: 29666157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression.
    Uccella S; Cerutti R; Placidi C; Marchet S; Carnevali I; Bernasconi B; Proserpio I; Pinotti G; Tibiletti MG; Furlan D; Capella C
    J Clin Pathol; 2009 Aug; 62(8):715-23. PubMed ID: 19638543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Common and HIV-related diffuse large B-cell lymphomas differ in their immunoglobulin gene mutation pattern.
    Delecluse HJ; Hummel M; Marafioti T; Anagnostopoulos I; Stein H
    J Pathol; 1999 Jun; 188(2):133-8. PubMed ID: 10398155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.